Facebook Linkedin RSS Twitter Youtube
Home 2024

Novo Nordisk

Force of Nature: Enveda Raises $130M, Advances Lead Pipeline Candidate
Artificial Intelligence

Force of Nature: Enveda Raises $130M, Advances Lead Pipeline Candidate

Squid Game: Direct Drug Delivery Into GI Tract Using Cephalopod-Inspired Capsules
Insights

Squid Game: Direct Drug Delivery Into GI Tract Using Cephalopod-Inspired Capsules

Thermo Fisher’s Accelerator Expands CRO, CDMO Services
Bioprocessing

Thermo Fisher’s Accelerator Expands CRO, CDMO Services

StockWatch: Investors Hammer Lilly as GLP-1 Sales Miss Forecasts
Drug Discovery

StockWatch: Investors Hammer Lilly as GLP-1 Sales Miss Forecasts

Novartis, Monte Rosa Launch Up-to-$2.1B Molecular Glue Collaboration
Drug Discovery

Novartis, Monte Rosa Launch Up-to-$2.1B Molecular Glue Collaboration

Pfizer, Triana Launch Up-to-$1.5B+ Molecular Glue Collaboration
Drug Discovery

Pfizer, Triana Launch Up-to-$1.5B+ Molecular Glue Collaboration

StockWatch: BioAge, Orum Reflect Renewed Interest in IPOs
Drug Discovery

StockWatch: BioAge, Orum Reflect Renewed Interest in IPOs

StockWatch: FDA Surprise Lifts Expectations for Applied’s Govorestat
Drug Discovery

StockWatch: FDA Surprise Lifts Expectations for Applied’s Govorestat

HAYA, Lilly Launch Up-to-$1B Metabolic Collaboration
Drug Discovery

HAYA, Lilly Launch Up-to-$1B Metabolic Collaboration

StockWatch: Lilly Narrows GLP-1 Revenue Gap with Novo Nordisk
Drug Discovery

StockWatch: Lilly Narrows GLP-1 Revenue Gap with Novo Nordisk

1234Page 1 of 4
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.